0001209191-21-049763.txt : 20210804 0001209191-21-049763.hdr.sgml : 20210804 20210804183248 ACCESSION NUMBER: 0001209191-21-049763 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Eli CENTRAL INDEX KEY: 0001534264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40656 FILM NUMBER: 211145597 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc. CENTRAL INDEX KEY: 0001858848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813789973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-865-2066 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-03 0 0001858848 Tenaya Therapeutics, Inc. TNYA 0001534264 Casdin Eli C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLR. SOUTH SAN FRANCISCO CA 94080 1 0 1 0 Common Stock 2021-08-03 4 C 0 2374849 0.00 A 2374849 I See Footnotes Common Stock 2021-08-03 4 P 0 850000 15.00 A 3224849 I See Footnotes Common Stock 2021-08-03 4 C 0 361969 0.00 A 361969 I See Footnotes Series B Preferred Stock 0.00 2021-08-03 4 C 0 2012880 D Common Stock 2012880 0 I See Footnotes Series C Preferred Stock 0.00 2021-08-03 4 C 0 361969 D Common Stock 361969 0 I See Footnotes Series C Preferred Stock 0.00 2021-08-03 4 C 0 361969 D Common Stock 361969 0 I See Footnotes These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF). Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any. These shares are held directly by Casdin Private Growth Equity Fund, L.P. (CPGEF). Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. /s/ Eli Casdin 2021-08-03